395 related articles for article (PubMed ID: 8827066)
21. Inactivation of WT1 in nephrogenic rests, genetic precursors to Wilms' tumour.
Park S; Bernard A; Bove KE; Sens DA; Hazen-Martin DJ; Garvin AJ; Haber DA
Nat Genet; 1993 Dec; 5(4):363-7. PubMed ID: 8298644
[TBL] [Abstract][Full Text] [Related]
22. WT1, WTX and CTNNB1 mutation analysis in 43 patients with sporadic Wilms' tumor.
Cardoso LC; De Souza KR; De O Reis AH; Andrade RC; Britto AC; De Lima MA; Dos Santos AC; De Faria PS; Ferman S; Seuánez HN; Vargas FR
Oncol Rep; 2013 Jan; 29(1):315-20. PubMed ID: 23117548
[TBL] [Abstract][Full Text] [Related]
23. Wilms tumor and the WT1 gene.
Lee SB; Haber DA
Exp Cell Res; 2001 Mar; 264(1):74-99. PubMed ID: 11237525
[TBL] [Abstract][Full Text] [Related]
24. Imbalanced expression of functionally different WT1 isoforms may contribute to sporadic unilateral Wilms' tumor.
Liu JJ; Wang ZY; Deuel TF; Xu YH
Biochem Biophys Res Commun; 1999 Jan; 254(1):197-9. PubMed ID: 9920757
[TBL] [Abstract][Full Text] [Related]
25. Genetics of Wilms' tumor.
Coppes MJ; Egeler RM
Semin Urol Oncol; 1999 Feb; 17(1):2-10. PubMed ID: 10073400
[TBL] [Abstract][Full Text] [Related]
26. A point mutation found in the WT1 gene in a sporadic Wilms' tumor without genitourinary abnormalities is identical with the most frequent point mutation in Denys-Drash syndrome.
Akasaka Y; Kikuchi H; Nagai T; Hiraoka N; Kato S; Hata J
FEBS Lett; 1993 Feb; 317(1-2):39-43. PubMed ID: 8381368
[TBL] [Abstract][Full Text] [Related]
27. A review of the phenotypic variation due to the Denys-Drash syndrome-associated germline WT1 mutation R362X.
Heathcott RW; Morison IM; Gubler MC; Corbett R; Reeve AE
Hum Mutat; 2002 Apr; 19(4):462. PubMed ID: 11933209
[TBL] [Abstract][Full Text] [Related]
28. Case report: WT1 exon 6 truncation mutation and ambiguous genitalia in a patient with Denys-Drash syndrome.
Chiang PW; Aliaga S; Travers S; Spector E; Tsai AC
Curr Opin Pediatr; 2008 Feb; 20(1):103-6. PubMed ID: 18197048
[TBL] [Abstract][Full Text] [Related]
29. Exclusion of the Wilms tumour gene (WT1) promoter as a site of frequent mutation in Wilms tumour.
Grubb GR; Yun K; Reeve AE; Eccles MR
Oncogene; 1995 Apr; 10(8):1677-81. PubMed ID: 7731725
[TBL] [Abstract][Full Text] [Related]
30. The Wilms' tumor gene WT1 can regulate genes involved in sex determination and differentiation: SRY, Müllerian-inhibiting substance, and the androgen receptor.
Shimamura R; Fraizer GC; Trapman J; Lau YfC ; Saunders GF
Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2571-80. PubMed ID: 9815658
[TBL] [Abstract][Full Text] [Related]
31. Nonlinkage of 16q markers to familial predisposition to Wilms' tumor.
Huff V; Reeve AE; Leppert M; Strong LC; Douglass EC; Geiser CF; Li FP; Meadows A; Callen DF; Lenoir G
Cancer Res; 1992 Nov; 52(21):6117-20. PubMed ID: 1356625
[TBL] [Abstract][Full Text] [Related]
32. Coordinate expression of Wilms' tumor genes correlates with Wilms' tumor phenotypes.
Yeger H; Cullinane C; Flenniken A; Chilton-MacNeil S; Campbell C; Huang A; Bonetta L; Coppes MJ; Thorner P; Williams BR
Cell Growth Differ; 1992 Dec; 3(12):855-64. PubMed ID: 1335280
[TBL] [Abstract][Full Text] [Related]
33. A clinical overview of WT1 gene mutations.
Little M; Wells C
Hum Mutat; 1997; 9(3):209-25. PubMed ID: 9090524
[TBL] [Abstract][Full Text] [Related]
34. Outcome of renal transplantation for Wilms' tumor and Denys-Drash syndrome: a report of the North American Pediatric Renal Transplant Cooperative Study.
Kist-van Holthe JE; Ho PL; Stablein D; Harmon WE; Baum MA
Pediatr Transplant; 2005 Jun; 9(3):305-10. PubMed ID: 15910385
[TBL] [Abstract][Full Text] [Related]
35. Atypical presentation of Denys-Drash syndrome in a female with a novel Wt1 gene mutation.
Machin GA
Birth Defects Orig Artic Ser; 1996; 30(1):269-86. PubMed ID: 9125334
[No Abstract] [Full Text] [Related]
36. Differentially spliced exon 5 of the Wilms' tumor gene WT1 modifies gene function.
Hewitt SM; Saunders GF
Anticancer Res; 1996; 16(2):621-6. PubMed ID: 8687106
[TBL] [Abstract][Full Text] [Related]
37. Molecular biology of Wilms' tumor.
Koo HP; Hensle TW
Urol Clin North Am; 1993 May; 20(2):323-31. PubMed ID: 8388135
[TBL] [Abstract][Full Text] [Related]
38. WT1 mutations associated with incomplete Denys-Drash syndrome define a domain predicted to behave in a dominant-negative fashion.
Bardeesy N; Zabel B; Schmitt K; Pelletier J
Genomics; 1994 Jun; 21(3):663-4. PubMed ID: 7959750
[No Abstract] [Full Text] [Related]
39. WT1 mutation as a cause of 46 XY DSD and Wilm's tumour: a case report and literature review.
Dai YL; Fu JF; Hong F; Xu S; Shen Z
Acta Paediatr; 2011 Jul; 100(7):e39-42. PubMed ID: 21314844
[TBL] [Abstract][Full Text] [Related]
40. Familial Wilms' tumor associated with a WT1 zinc finger mutation.
Kaplinsky C; Ghahremani M; Frishberg Y; Rechavi G; Pelletier J
Genomics; 1996 Dec; 38(3):451-3. PubMed ID: 8975729
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]